TGF-β induces novel Lef-1 splice variants through a Smad-independent signaling pathway

Developmental Dynamics

Volumn 232, Issue 4, 2005, Pages 969-978

  Cordray, Pauline ^a   Satterwhite, Daniel J ^b,c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NONE   (United States)

Author keywords

catenin; APC; Lef 1; Smad; TCF; TGF ; Wnt

Indexed keywords

BETA CATENIN; LYMPHOID ENHANCER FACTOR 1; MYC PROTEIN; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ARTICLE; CELL LINE; CELL SPECIFICITY; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE INDUCTION; GENETIC VARIABILITY; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DNA-BINDING PROTEINS; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; MINK; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; RATS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 16244407436     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.20275     Document Type: Article

References (41)

1. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. 1996. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638-642.
2. Bell E, Munoz-Sanjuan I, Altmann CR, Vonica A, Brivanlou AH. 2003. Cell fate specification and competence by Coco, a maternal BMP, TGFbeta and Wnt inhibitor. Development 130:1381-1389.
3. Billin AN, Thirlwell H, Ayer DE. 2000. Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol 20:6882-6890.
4. Capdevila J, Belmonte JC. 1999. Extracellular modulation of the Hedgehog, Wnt and TGF-beta signalling pathways during embryonic development. Curr Opin Genet Dev 9:427-433.
5. Carlsson P, Waterman ML, Jones KA. 1993. The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells. Genes Dev 7:2418-2430.
6. Clements WM, Lowy AM, Groden J. 2003. Adenomatous polyposis coli/beta-catenin interaction and downstream targets: altered gene expression in gastrointestinal tumors. Clin Colorectal Cancer 3:113-120.
7. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG. 1988. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261-267.
8. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-betafamilysignalling. Nature 425:577-584.
9. Duan D, Sehgal A, Yao J, Engelhardt JF. 1998. Lef1 transcription factor expression defines airway progenitor cell targets for in utero gene therapy of submucosal gland in cystic fibrosis. Am J Respir Cell Mol Biol 18:750-758.
10. Duan D, Yue Y, Zhou W, Labed B, Ritchie TC, Grosschedl R, Engelhardt JF. 1999. Submucosal gland development in the airway is controlled by lymphoid enhancer binding factor 1 (LEF1). Development 126:4441-4453.
11. Giese K, Grosschedl R. 1993. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J 12:4667-4676.
12. Giese K, Cox J, Grosschedl R. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69:185-195.
13. Giles RH, van Es JH, Clevers H. 2003. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653:1-24.
14. Grainger DJ, Mosedale DE, Metcalfe JC, Weissberg PL, Kemp PR. 1995. Active and acid-activatable TGF-beta in human sera, platelets and plasma. Clin Chim Acta 235:11-31.
15. Heck MM, Earnshaw WC. 1986. Topoisomerase II: a specific marker for cell proliferation. J Cell Biol 103:2569-2581.
16. Henderson IC, Lieber MM, Todaro GJ. 1974. Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses. Virology 60:282-287.
17. Henderson BR, Galea M, Schuechner S, Leung L. 2002. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1. J Biol Chem 277: 24258-24264.
18. Hovanes K, Li TW, Waterman ML. 2000. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 28:1994-2003.
19. Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF, Waterman ML. 2001. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28:53-57.
20. Hu MC, Piscione TD, Rosenblum ND. 2003. Elevated SMAD1/beta-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice. Development 130:2753-2766.
21. Korchynskyi O, ten Dijke P. 2002. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277:4883-4891.
22. Kratochwil K, Dull M, Farinas I, Galceran J, Grosschedl R. 1996. Lef1 expression is activated by BMP-4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev 10:1382-1394.
23. Labbe E, Letamendia A, Attisano L. 2000. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci U S A 97:8358-8363.
24. Lee DK, Kim BC, Kim IY, Cho EA, Satterwhite DJ, Kim SJ. 2002, The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence. J Biol Chem 277:38557-38564.
25. Letamendia A, Labbe E, Attisano L. 2001. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am 83(Suppl 1):S31-S39.
26. Massague J, Blain SW, Lo RS. 2000. TGF-beta signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
27. Nawshad A, Hay ED. 2003. TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J Cell Biol 163:1291-1301.
28. Niehrs C. 1999. Head in the WNT: the molecular nature of Spemann's head organizer. Trends Genet 15:314-319.
29. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. 2000. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403:781-785.
30. Piccolo S, Agius E, Leyns L, Bhattacharyya S, Grunz H, Bouwmeester T, De Robertis EM. 1999. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature 397:707-710.
31. Polakis P. 2000. Wnt signaling and cancer. Genes Dev 14:1837-1851.
32. Riese J, Yu X, Munnerlyn A, Eresh S, Hsu SC, Grosschedl R, Bienz M. 1997. LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 88:777-787.
33. Sasaki T, Suzuki H, Yagi K, Furuhashi M, Yao R, Susa S, Noda T, Arai Y, Miyazono K, Kato M. 2003. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Cancer Res 63:801-806.
34. Satterwhite DJ, Neufeld KL. 2004. TGF-β Targets the Wnt pathway components, APC and β-catenin, as Mv1Lu cells undergo cell cycle arrest. Cell Cycle 8:1069-1073.
35. Satterwhite DJ, Aakre ME, Gorska AE, Moses HL. 1994. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells. Cell Growth Differ 5:789-799.
36. Satterwhite DJ, Matsunami N, White RL. 2000a. TGF-beta1 inhibits BRCA1 expression through a pathway that requires pRb. Biochem Biophys Res Commun 276:686-692.
37. Satterwhite DJ, White RL, Matsunami N, Neufeld KL. 2000b. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein. Cancer Res 60:6989-6994.
38. Satterwhite DJ, White RL, Aakre ME, Moses HL. 2001. TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1. Pediatr Res 50:67-75.
39. van Genderen C, Okamura RM, Farinas I, Quo RG, Parslow TG, Bruhn L, Grosschedl R. 1994. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 8:2691-2703.
40. Vivien D, Attisano L, Wrana JL, Massague J. 1995. Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes. J Biol Chem 270:7134-7141.
41. Zhou P, Byrne C, Jacobs J, Fuchs E. 1995. Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes Dev 9:700-713.